Reproducible chemostat cultures to minimize eukaryotic viruses from fecal transplant material

Signe Adamberg1, Torben Sølbeck Rasmussen2, Sabina Brigitte Larsen2

  • 1Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, Tallinn, Estonia.

Iscience
|August 6, 2024
PubMed

Insights

Fecal microbiota transplantation (FMT) can be improved using a novel cultivation method. This approach enhances reproducibility and reduces infection risks from viruses, paving the way for safer gut disease therapies.

Area of Science:

  • Microbiology
  • Virology
  • Gastroenterology

Background:

  • Bacteriophages are crucial for fecal microbiota transplantation (FMT) success.
  • Clinical FMT applications are limited by donor variability and infection risks (bacteria, viruses).

Purpose of the Study:

  • To develop a cultivation method for FMT preparation that reduces eukaryotic virus contamination.
  • To assess the impact of this method on bacterial and phage populations and overall virome diversity.

Main Methods:

  • Propagating mouse cecal and human fecal material in a chemostat fermentation system.
  • The system was designed to support bacteria and phage growth while preventing eukaryotic virus propagation.
  • Virome profiles were analyzed to assess viral abundance and diversity.

Main Results:

  • A significant decrease in the relative abundance of eukaryotic viruses (below 0.01%) was observed.
  • Virome profiles demonstrated dilution rate dependency and reproducibility across biological replicates.
  • High diversity of human and mouse inocula was maintained.

Conclusions:

  • This chemostat cultivation approach offers a proof-of-concept for safer, more reproducible FMT preparations.
  • It may lead to novel therapeutic tools for gut-related diseases with reduced infection risks.